Inhibikase Therapeutics logo
Inhibikase Therapeutics
IKT | NASDAQ
Chart Builder DCF Calculator
$1.45
-$0.07 (-4.61%)
At close: Nov 16, 2026, 4:00 PM ET
$1.45
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET

Inhibikase Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-20.47M -19.59M -16.38M -12.73M -11.93M -9.92M -13.68M -12.13M -5.78M -4.96M -4.65M -4.18M -4.6M -5.78M -4.48M -4.28M -4.49M -4.64M -4.64M -5.04M -4.47M -2.64M -2.64M
– – – – 23.69K 24.16K 12.65K 6.57K 6.57K 6.57K 6.57K 6.57K 6.58K 159.2K 5.04K 5.04K 1.68K 4.64M 4.64M 5.04M 4.47M 2.63M 2.63M
5.53M 5.35M 5.56M 4.53M 4.53M 4.21M 2.04M 7.91M 148.02K 30.7K 53.43K 122.25K 129.78K 124.85K 123.27K 100.36K 101.79K 132.77K 123.23K 265.85K 352.42K 322.48K 591.12K
-1.17M 4.01M -479.62K -128.33K -164.66K -445.02K 647.1K -70.67K 288.94K -528.47K 243.35K 680.23K 276.45K 1.15M -1.41M 294.18K -1.05M 55.7K 737.59K 6.8K 1.88M -2.09M -817.66K
-1.23M -1.58M -1.19M 275.7K -1.06M -358.42K 6.19M – – – – 14.26K 17.28K 663.27K – -20.82K 20.82K -4.64M -4.57M -5.01M -4.29M -2.39M -2.35M
– – – – – – – – – – – – – -663.27K – – – – – – – – –
-1.18M 3.39M -50.37K 409.2K -2.15M 466.81K 1.33M -1.13M 742.37K -132.03K 722.62K 592.44K 336.46K 928.53K -1.62M 638.09K -1.13M 151.37K 516.18K 650.11K 1.92M -2.17M -2.16M
-17.35M -12.44M -12.06M -7.52M -10.59M -5.57M -4.1M -5.35M -4.88M -5.05M -3.87M -3.44M -4.11M -4.57M -5.97M -3.56M -5.5M -4.36M -3.93M -4.1M -2.02M -4.25M -3.93M
– – – -452.02K – – – – – – – – – -14.24K – – -200.17K -43.09K -3 -3 -2 -4 –
– – – – – – – – – – – – – 14.24K – – – – – – – – –
-75.69M -55.03M -90.58M -98.85K -39M – – -50.11M -1.13M -776.97K -8.43M -8.8M -1.95M 2.93M -21.61M – -20.73M – – – – – –
63.08M 49.13M 10.1M – 10.25M 9.84M 21.51M 11.35M 3.66M 3.32M 5.12M 6.68M 19.01M -365.66K 15.77M – – – – – – – –
– – – 452.02K – – – – – – – – – -14.24K – 4.96M – – – – – – –
-12.61M -5.91M -80.48M -98.85K -28.75M 9.84M 21.05M -38.76M 2.53M 2.54M -3.31M -2.12M 17.06M 2.55M -5.84M 4.96M -20.93M -43.09K – – – – –
– – – – – – – – – – – – – – – – – – -248.91K – – 367.13K -409.66K
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
-18.03K -14.49K – 385.06K -385.06K 31.62K – – – 30.61K -30.61K -138.56K – – – – – – – – 44.14K -43.3K –
50.46M -14.49K 2.9M 108.57M -134.13K 31.77K – 99.68M 181.95K 3.24M 367K -138.1K 70 -35.99K 8.58M – – – -204.77K – 29.89K 41.47M -409.66K
20.49M -18.37M -89.65M 100.95M -39.47M 4.3M 16.95M 55.58M -2.17M 733.11K -6.81M -5.7M 12.96M -2.05M -3.23M 1.41M -26.43M -4.4M -4.14M -4.1M -1.99M 37.23M -4.34M
-17.35M -12.44M -12.06M -7.97M -10.59M -5.57M -4.1M -5.35M -4.88M -5.05M -3.87M -3.44M -4.11M -4.58M -5.97M -3.56M -5.7M -4.4M -3.93M -4.1M -2.02M -4.25M -3.93M
-22.88M -17.79M -17.62M -12.5M -15.12M -9.78M -6.15M -13.25M -5.03M -5.09M -3.92M -3.56M -4.23M -4.7M -6.1M -3.66M -5.81M -4.53M -4.06M -4.36M -2.37M -4.57M -4.53M
– – – -452.02K – – – – – – – – – -5.95K – – -200.17K -43.09K -3 -3 -2 -4 –
– – – – – – – – – – – – – -8.29K – – – – – – – – –
-17.35M -12.44M -12.06M -7.97M -10.59M -5.57M -4.1M -5.35M -4.88M -5.05M -3.87M -3.44M -4.11M -4.57M -5.97M -3.56M -5.7M -4.4M -3.93M -4.1M -2.02M -4.25M -3.93M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.